Testing a new medication's safety and how the body processes it

This is a Phase 1 safety trial of Amisodin, an experimental oral medication being developed to treat amyotrophic lateral sclerosis (ALS). The trial will test whether the medication is safe and how the body absorbs, processes, and eliminates it. Researchers will start with small doses and gradually increase them to find the safest dose range.

Before this medication can be tested in patients with ALS, it must first be proven safe in healthy volunteers. This trial will also show how the body handles the medication and whether food affects how it is absorbed—information needed before moving to later-stage testing.